The first Alnylam Pharmaceuticals trade was made in Q3 2014. Since then Steven Cohen bought shares twelve more times and sold shares on thirteen occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Alnylam Pharmaceuticals anymore.